{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T23:20:38Z","timestamp":1771629638956,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,4,4]],"date-time":"2014-04-04T00:00:00Z","timestamp":1396569600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1007\/s40618-014-0069-6","type":"journal-article","created":{"date-parts":[[2014,4,3]],"date-time":"2014-04-03T06:40:04Z","timestamp":1396507204000},"page":"477-495","source":"Crossref","is-referenced-by-count":54,"title":["Achieving HbA1c targets in clinical trials and in the real world: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"37","author":[{"given":"Edoardo","family":"Mannucci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Monami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Dicembrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Attilio","family":"Piselli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Porta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,4]]},"reference":[{"issue":"4","key":"69_CR1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199807233390404","volume":"339","author":"SM Haffner","year":"1998","unstructured":"Haffner SM, Lehto S, R\u00f6nnemaa T, Py\u00f6r\u00e4l\u00e4 K, Laakso M (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339(4):229\u2013234","journal-title":"N Engl J Med"},{"issue":"19","key":"69_CR2","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1001\/jama.287.19.2570","volume":"287","author":"JA Beckman","year":"2002","unstructured":"Beckman JA, Creager MA, Libby P (2002) Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 287(19):2570\u20132581","journal-title":"JAMA"},{"key":"69_CR3","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","volume":"329","author":"The Diabetes Control and Complications Trial Research Group","year":"1993","unstructured":"The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977\u2013986","journal-title":"N Engl J Med"},{"key":"69_CR4","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","unstructured":"UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837\u2013853","journal-title":"Lancet"},{"issue":"24","key":"69_CR5","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","volume":"358","author":"A Patel","year":"2008","unstructured":"ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J et al (2008) Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358(24):2560\u20132572","journal-title":"N Engl J Med"},{"issue":"9","key":"69_CR6","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.numecd.2009.03.021","volume":"19","author":"E Mannucci","year":"2009","unstructured":"Mannucci E, Monami M, Lamanna C, Gori F, Marchionni N (2009) Prevention of cardiovascular disease through glycemic control in type 2 diabetes: a meta-analysis of randomized clinical trials. Nutr Metab Cardiovasc Dis 19(9):604\u2013612","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"69_CR7","doi-asserted-by":"crossref","first-page":"d4169","DOI":"10.1136\/bmj.d4169","volume":"343","author":"R Boussageon","year":"2011","unstructured":"Boussageon R, Bejan-Angoulvant T, Saadatian-Elahi M et al (2011) Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials. BMJ 343:d4169","journal-title":"BMJ"},{"issue":"6","key":"69_CR8","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.2337\/dc12-0413","volume":"35","author":"SE Inzucchi","year":"2012","unstructured":"Inzucchi SE, Bergenstal RM, Buse JB, American Diabetes Association (ADA), European Association for the Study of Diabetes (EASD) et al (2012) Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 35(6):1364\u20131379","journal-title":"Diabetes Care"},{"key":"69_CR9","unstructured":"American Association of Clinical Endocrinologist (2007) Medical guidelines for clinical practice for the management of diabetes mellitus. http:\/\/www.aace.com"},{"issue":"6","key":"69_CR10","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1464-5491.2006.01918.x","volume":"23","author":"IDF Clinical Guidelines Task Force","year":"2006","unstructured":"IDF Clinical Guidelines Task Force (2006) Global Guideline for Type 2 Diabetes: recommendations for standard, comprehensive, and minimal care. Diabet Med 23(6):579\u2013593","journal-title":"Diabet Med"},{"key":"69_CR11","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151:264\u2013269","journal-title":"Ann Intern Med"},{"issue":"1","key":"69_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","volume":"17","author":"AR Jadad","year":"1996","unstructured":"Jadad AR, Moore RA, Carroll D et al (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trial 17(1):1\u201312","journal-title":"Control Clin Trial"},{"key":"69_CR13","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","volume":"50","author":"CB Begg","year":"1994","unstructured":"Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088\u20131101","journal-title":"Biometrics"},{"key":"69_CR14","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey SG, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629\u2013634","journal-title":"BMJ"},{"issue":"3","key":"69_CR15","doi-asserted-by":"crossref","first-page":"496","DOI":"10.2337\/dc06-1406","volume":"30","author":"K Eeg-Olofsson","year":"2007","unstructured":"Eeg-Olofsson K, Cederholm J, Nilsson PM, Gudbj\u00f6rnsd\u00f3ttir S, Eliasson B, Steering Committee of the Swedish National Diabetes Register (2007) Glycemic and risk factor control in type 1 diabetes: results from 13,612 patients in a national diabetes register. Diabetes Care 30(3):496\u2013502","journal-title":"Diabetes Care"},{"key":"69_CR16","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1111\/j.1464-5491.2005.01648.x","volume":"22","author":"B Eliasson","year":"2005","unstructured":"Eliasson B, Cederholm J, Nilsson P, Gudbj\u00f6rnsd\u00f3ttir S (2005) The gap between guidelines and reality: type 2 diabetes in a National Diabetes Register 1996\u20132003. Diabet Med 22:1420\u20131426","journal-title":"Diabet Med"},{"key":"69_CR17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.numecd.2006.08.007","volume":"18","author":"G Bruno","year":"2008","unstructured":"Bruno G, Merletti F, Bargero G et al (2008) Changes over time in the prevalence and quality of care of type 2 diabetes in Italy: the Casale Monferrato surveys, 1988 and 2000. Nutr Metab Cardiovasc Dis 18:39\u201345","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"69_CR18","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1001\/jama.291.3.335","volume":"291","author":"SH Saydah","year":"2004","unstructured":"Saydah SH, Fradkin J, Cowie CC (2004) Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 291:335\u2013342","journal-title":"JAMA"},{"key":"69_CR19","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2337\/dc07-0565","volume":"31","author":"ES Ford","year":"2008","unstructured":"Ford ES, Li C, Little RR, Mokdad AH (2008) Trends in A1C concentrations among US adults with diagnosed diabetes from 1999 to 2004. Diabetes Care 31:102\u2013104","journal-title":"Diabetes Care"},{"key":"69_CR20","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.2337\/diacare.26.4.1258","volume":"26","author":"P Hovind","year":"2003","unstructured":"Hovind P, Tarnow L, Rossing K et al (2003) Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. Diabetes Care 26:1258\u20131264","journal-title":"Diabetes Care"},{"key":"69_CR21","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/j.ophtha.2008.08.023","volume":"115","author":"R Klein","year":"2008","unstructured":"Klein R, Knudtson MD, Lee KE, Gangnon R, Klein BEK (2008) The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXII. The twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology 115:1859\u20131868","journal-title":"Ophthalmology"},{"key":"69_CR22","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMra1005073","volume":"366","author":"DA Antonetti","year":"2012","unstructured":"Antonetti DA, Klein R, Gardner TW (2012) Diabetic retinopathy. NEJM 366:1227\u20131239","journal-title":"NEJM"},{"key":"69_CR23","first-page":"859","volume":"56","author":"SK Sharma","year":"2008","unstructured":"Sharma SK, Joshi SR, Kumar A, Unnikrishnan AG, Hoskote SS, Moharana AK, Chakkarwar PN, Vaz JA, PRESENT Study Group (2008) Efficacy, safety and acceptability of biphasic insulin aspart 30 in Indian patients with type 2 diabetes: results from the PRESENT study. J Assoc Physicians India 56:859\u2013863","journal-title":"J Assoc Physicians India"},{"issue":"3","key":"69_CR24","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1185\/030079908X260952","volume":"24","author":"SK Sharma","year":"2008","unstructured":"Sharma SK, Al-Mustafa M, Oh SJ, Azar ST, Shestakova M, Guler S, Vaz JA (2008) Biphasic insulin aspart 30 treatment in patients with type 2 diabetes poorly controlled on prior diabetes treatment: results from the PRESENT study. Curr Med Res Opin 24(3):645\u2013652","journal-title":"Curr Med Res Opin"},{"issue":"5","key":"69_CR25","doi-asserted-by":"crossref","first-page":"927","DOI":"10.2337\/dc07-1863","volume":"31","author":"L Hanberger","year":"2008","unstructured":"Hanberger L, Samuelsson U, Lindblad B, Ludvigsson J, Swedish Childhood Diabetes Registry SWEDIABKIDS (2008) A1C in children and adolescents with diabetes in relation to certain clinical parameters: the Swedish Childhood Diabetes Registry SWEDIABKIDS. Diabetes Care 31(5):927\u2013929 (Epub 2008 Jan 30)","journal-title":"Diabetes Care"},{"issue":"5","key":"69_CR26","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1089\/dia.2007.0296","volume":"10","author":"CY Pan","year":"2008","unstructured":"Pan CY, Ho LT, Soegondo S, Prodjosudjadi W, Suwanwalaikorn S, Lim SC, Chan TM, Chow KW, Thoenes M, Choi DS, DEMAND Study Investigators (2008) Prevalence of albuminuria and cardiovascular risk profile in a referred cohort of patients with type 2 diabetes: an Asian perspective. Diabetes Technol Ther 10(5):397\u2013403","journal-title":"Diabetes Technol Ther"},{"issue":"4","key":"69_CR27","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1464-5491.2008.02391.x","volume":"25","author":"C Pan","year":"2008","unstructured":"Pan C, Yang W, Barona JP, Wang Y, Niggli M, Mohideen P, Wang Y, Foley JE (2008) Comparison of vildagliptin and acarbose monotherapy in patients with type 2 diabetes: a 24-week, double-blind, randomized trial. Diabet Med 25(4):435\u2013441 Epub 2008 Mar 13","journal-title":"Diabet Med"},{"issue":"6","key":"69_CR28","doi-asserted-by":"crossref","first-page":"339","DOI":"10.5694\/j.1326-5377.2009.tb02819.x","volume":"191","author":"NW Cheung","year":"2009","unstructured":"Cheung NW, Conn JJ, d\u2019Emden MC, Gunton JE, Jenkins AJ, Ross GP, Sinha AK, Andrikopoulos S, Colagiuri S, Twigg SM, Australian Diabetes Society (2009) Position statement of the Australian Diabetes Society: individualisation of glycated haemoglobin targets for adults with diabetes mellitus. Med J Aust 191(6):339\u2013344","journal-title":"Med J Aust"},{"issue":"1","key":"69_CR29","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.diabres.2009.07.009","volume":"87","author":"U Pl\u00f6ckinger","year":"2010","unstructured":"Pl\u00f6ckinger U, Topuz M, Langer M, Reuter T (2010) Problems of diabetes management in the immigrant population in Germany. Diabetes Res Clin Pract 87(1):77\u201386","journal-title":"Diabetes Res Clin Pract"},{"issue":"6 Suppl","key":"69_CR30","first-page":"16","volume":"48","author":"SH Kaplan","year":"2010","unstructured":"Kaplan SH, Billimek J, Sorkin DH, Ngo-Metzger Q, Greenfield S (2010) Who can respond to treatment? Identifying patient characteristics related to heterogeneity of treatment effects. Med Care 48(6 Suppl):16 (Diabetes Res Clin Pract. 2006; 73(2):198\u2013204)","journal-title":"Med Care"},{"issue":"3","key":"69_CR31","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.diabres.2008.09.006","volume":"82","author":"PC Tong","year":"2008","unstructured":"Tong PC, Ko GT, So WY, Chiang SC, Yang X, Kong AP, Ozaki R, Ma RC, Cockram CS, Chow CC, Chan JC (2008) Use of anti-diabetic drugs and glycaemic control in type 2 diabetes\u2014The Hong Kong Diabetes Registry. Diabetes Res Clin Pract 82(3):346\u2013352","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"69_CR32","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/qjmed\/hcm150","volume":"101","author":"A Elis","year":"2008","unstructured":"Elis A, Rosenmann L, Chodick G, Heymann AD, Kokia E, Shalev V (2008) The association between glycemic, lipids and blood pressure control among Israeli diabetic patients. QJM 101(4):275\u2013280","journal-title":"QJM"},{"issue":"888","key":"69_CR33","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1136\/pgmj.75.888.603","volume":"75","author":"RT Erasmus","year":"1999","unstructured":"Erasmus RT, Blanco Blanco E, Okesina AB, Gqweta Z, Matsha T (1999) Assessment of glycaemic control in stable type 2 black South African diabetics attending a peri-urban clinic. Postgrad Med J 75(888):603\u2013606","journal-title":"Postgrad Med J"},{"issue":"3","key":"69_CR34","doi-asserted-by":"crossref","first-page":"514","DOI":"10.2337\/diacare.28.3.514","volume":"28","author":"DJ Wexler","year":"2005","unstructured":"Wexler DJ, Grant RW, Meigs JB, Nathan DM, Cagliero E (2005) Sex disparities in treatment of cardiac risk factors in patients with type 2 diabetes. Diabetes Care 28(3):514\u2013520","journal-title":"Diabetes Care"},{"issue":"3","key":"69_CR35","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1001\/jama.291.3.335","volume":"291","author":"SH Saydah","year":"2004","unstructured":"Saydah SH, Fradkin J, Cowie CC (2004) Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 291(3):335\u2013342","journal-title":"JAMA"},{"issue":"1","key":"69_CR36","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/qshc.2006.018648","volume":"16","author":"FA McAlister","year":"2007","unstructured":"McAlister FA, Majumdar SR, Eurich DT, Johnson JA (2007) The effect of specialist care within the first year on subsequent outcomes in 24,232 adults with new-onset diabetes mellitus: population-based cohort study. Qual Saf Health Care 16(1):6\u201311","journal-title":"Qual Saf Health Care"},{"key":"69_CR37","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/BF00400637","volume":"38","author":"M Muggeo","year":"1995","unstructured":"Muggeo M, Verlato G, Bonora E et al (1995) The Verona Diabetes Study: a population-based survey on known diabetes mellitus prevalence and 5-year all-cause mortality. Diabetologia 38:318","journal-title":"Diabetologia"},{"issue":"4","key":"69_CR38","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2337\/dc09-2024","volume":"33","author":"M Trento","year":"2010","unstructured":"Trento M, Gamba S, Gentile L, ROMEO Investigators et al (2010) Rethink Organization to iMprove Education and Outcomes (ROMEO): a multicenter randomized trial of lifestyle intervention by group care to manage type 2 diabetes. Diabetes Care 33(4):745\u2013747","journal-title":"Diabetes Care"},{"key":"69_CR39","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/qjmed\/hcg143","volume":"96","author":"G Gill","year":"2003","unstructured":"Gill G (2003) Intensified treatment of type 2 diabetes\u2014positive effects on blood pressure, but not glycaemic control. QJM 96:833\u2013836","journal-title":"QJM"},{"key":"69_CR40","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","volume":"358","author":"HC Gerstein","year":"2008","unstructured":"Gerstein HC, Miller ME, Byington RP et al (2008) Effects of intensive glucose lowering in type 2 diabetes. NEJM 358:2545\u20132559","journal-title":"NEJM"},{"key":"69_CR41","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1056\/NEJMoa021778","volume":"348","author":"P Gaede","year":"2003","unstructured":"Gaede P, Vedel P, Larsen N et al (2003) Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. NEJM 348:383\u2013393","journal-title":"NEJM"},{"issue":"1","key":"69_CR42","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1464-5491.2009.02867.x","volume":"27","author":"A Haugstvedt","year":"2010","unstructured":"Haugstvedt A, Wentzel-Larsen T, Graue M, S\u00f8vik O, Rokne B (2010) Fear of hypoglycaemia in mothers and fathers of children with Type 1 diabetes is associated with poor glycaemic control and parental emotional distress: a population-based study. Diabet Med 27(1):72\u201378","journal-title":"Diabet Med"},{"issue":"5","key":"69_CR43","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1037\/a0025259","volume":"25","author":"LM Drew","year":"2011","unstructured":"Drew LM, Berg C, King P et al (2011) Depleted parental psychological resources as mediators of the association of income with adherence and metabolic control. J Fam Psychol 25(5):751\u2013758","journal-title":"J Fam Psychol"},{"key":"69_CR44","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.diabet.2011.03.004","volume":"37","author":"G Reach","year":"2011","unstructured":"Reach G, Michault A, Bihan H et al (2011) Patients\u2019 impatience is an independent determinant of poor diabetes control. Diabetes Metab 37:497\u2013504","journal-title":"Diabetes Metab"},{"key":"69_CR45","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2147\/PPA.S24518","volume":"5","author":"G Reach","year":"2011","unstructured":"Reach G (2011) Obedience and motivation as mechanisms for adherence to medication: a study in obese type 2 diabetic patients. Patient Prefer Adherence 5:523\u2013531","journal-title":"Patient Prefer Adherence"},{"key":"69_CR46","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1001\/jama.2010.785","volume":"303","author":"IB Hirsch","year":"2010","unstructured":"Hirsch IB, Brownlee M (2010) Beyond haemoglobin A1c\u2014need for additional markers of risk for diabetic microvascular complications. JAMA 303:2291\u20132292","journal-title":"JAMA"},{"key":"69_CR47","doi-asserted-by":"crossref","first-page":"d6898","DOI":"10.1136\/bmj.d6898","volume":"343","author":"B Hemmingsen","year":"2011","unstructured":"Hemmingsen B, Lund SS, Gluud C et al (2011) Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials. BMJ 343:d6898","journal-title":"BMJ"},{"key":"69_CR48","doi-asserted-by":"crossref","unstructured":"Standards of Medical Care in Diabetes (2012) Diabetes Care 35:S11\u2013S63","DOI":"10.2337\/dc12-s011"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-014-0069-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-014-0069-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-014-0069-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T05:07:01Z","timestamp":1597640821000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-014-0069-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,4]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["69"],"URL":"https:\/\/doi.org\/10.1007\/s40618-014-0069-6","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,4]]}}}